logo
Russia warns US, South Korea and Japan against forming security alliance targeting North Korea

Russia warns US, South Korea and Japan against forming security alliance targeting North Korea

Washington Post12-07-2025
SEOUL, South Korea — Russia's foreign minister on Saturday warned the U.S., South Korea and Japan against forming a security partnership targeting North Korea as he visited his country's ally for talks on further solidifying their booming military and other cooperation.
Russian Foreign Minister Sergey Lavrov flew to North Korea's eastern Wonsan city on Friday for a meeting with his North Korean counterpart Choe Son Hui.
Relations between Russia and North Korea have been flourishing in recent years, with North Korea supplying troops and ammunitions to support Russia's war against Ukraine in return for military and economic assistance. That has raised concerns among South Korea, the U.S. and others that Russia might also transfer to North Korea sensitive technologies that can increase the danger of its nuclear and missile programs.
After a meeting with Choe on Saturday, Lavrov accused the U.S., South Korea and Japan of what he called their military buildups around North Korea.
'We warn against exploiting these ties to build alliances directed against anyone, including North Korea and, of course, Russia,' he told reporters, according to Russia's state Tass news agency.
The U.S., South Korea and Japan have been expanding or restoring their trilateral military exercises in response to North Korea's advancing nuclear program. On Friday, the three countries held a joint air drill involving U.S. nuclear-capable bombers near the Korean Peninsula, as their top military officers met in Seoul and urged North Korea to cease all unlawful activities that threaten regional security.
North Korea views major U.S.-led military drills as invasion rehearsals. It has long argued that it's forced to develop nuclear weapons to defend itself from U.S. military threats.
Lavrov said Russia understands North Korea's decision to seek nuclear weapons.
'The technologies used by North Korea are the result of the work of its own scientists. We respect North Korea's aspirations and understand the reasons why it is pursuing a nuclear development,' Lavrov said.
During their meeting, Choe reiterated that North Korea 'unconditionally' supports Russia's fight against Ukraine. She described ties between North Korea and Russia as 'the invincible alliance.'
Lavrov said he repeated Russia's gratitude for the contribution that North Korean troops made in efforts to repel a Ukrainian incursion into Russia's Kursk border region .
Wonsan city, the meeting venue, is where North Korea recently opened a mammoth beach resort that it says can accommodate nearly 20,000 people.
In his comments at the start of his meeting with Choe, Lavrov said that 'I am sure that Russian tourists will be increasingly eager to come here. We will do everything we can to facilitate this, creating conditions for this, including air travel,' according to the Russian Foreign Ministry.
The Wonsan-Kalma tourist zone is at the center of North Korean leader Kim Jong Un's push to boost tourism as a way to improve his country's troubled economy. But prospects for the biggest tourist complex in North Korea aren't clear, as the country appears unlikely to fully reopen its borders and embrace Western tourists anytime soon.
___
Associated Press writer Elise Morton in Athens, Greece contributed to this report.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US-EU trade deal impacts on pharma industry more 'manageable' than expected
US-EU trade deal impacts on pharma industry more 'manageable' than expected

Yahoo

time11 minutes ago

  • Yahoo

US-EU trade deal impacts on pharma industry more 'manageable' than expected

A 15% import tariff on pharmaceutical goods from the European Union to the US is going to have a lesser impact on the pharmaceutical industry than Wall Street feared. Big pharmaceutical stocks like Pfizer (PFE), Eli Lilly (LLY), and Johnson & Johnson (JNJ) rose slightly, by about 1%, in trading Thursday after the trade deal was announced, putting to rest concerns of tariffs threatened as high as 200% previously by President Trump. "The two regions have established a 15% tariff cap on imported drugs from EU to the US. This is being viewed by most as both manageable and below the 20%+ rate many expected," wrote Mizuho's healthcare expert Jared Holz in a note to clients Thursday. The deal outlined by the US and EU has multiple parts that impact the pharmaceutical industry, with some clarity still needed. The first is levying either the 15% tariff or the Most Favored Nation (MFN) pricing, whichever is higher, on pharma drugs manufactured in the EU. This puts more emphasis on President Trump's efforts to equalize US drug costs to the lower prices seen in the EU and other developed nations and also impacts a smaller portion of products, as pharma executives have emphasized that most of the branded drugs sold in the US are made in the US. But questions remain on whether the finalize products, or some components, will be taxed. "The United States commits to apply the higher of either the US MFN tariff rate or a tariff rate of 15 percent, comprised of the MFN tariff and a reciprocal tariff, on originating goods of the European Union," according to the White House statement. The second part of the deal is that, as of Sept. 1, the US will enforce MFN pricing on generics and "chemical precursors." The latter refers to active pharmaceutical ingredients, which are the key chemical compounds in any drug. They are cheaper to mass-produce overseas, largely in Asia or Ireland. Experts say that prices for generics, which account for a majority of prescriptions filled in the US, are already low. "The administration is, for the time being, focusing Most Favored Nations pricing on generic products — hoping to peg US prices to that of other countries. Given the already lower cost of generic medicines and net price paid domestically, see the financial ramifications here as more limited than not. Have to look deeper at what precise drugs will be subject to this regulation but for now, not a strategy we see as stifling the industry/major players," Mizuho's Holz said. Its why big generics players, like Teva (TEVA), saw their stocks also rise on the news — up more than 4% Thursday. UBS analyst Ashwani Verma called the trade deal a positive for drugmakers, in a note to clients Thursday. The deal also left wiggle room for additional items: "The United States and the European Union agree to consider other sectors and products that are important for their economies and value chains for inclusion in the list of products for which only the MFN tariffs would apply," according to the White House statement. J.P. Morgan analyst Chris Schott told clients Thursday that clarity on details — including which components are chosen and how the tariffs are levied — as well as the pending results of an investigation by the US Department of Commerce Bureau of Industry and Security, will determine the final impact. In addition, Schott noted that many companies have already stocked up on products in advance of the expected tariff deal, and have inventory through mid-2026. "In the near-term, we see inventory stocking as largely limiting the impact of tariffs through mid-to-late 2026 or longer in some cases," Schott said. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Click here for in-depth analysis of the latest health industry news and events impacting stock prices

EU Urges Wine, Spirits Tariff Cut as 15% US Duty Irks Industry
EU Urges Wine, Spirits Tariff Cut as 15% US Duty Irks Industry

Bloomberg

time14 minutes ago

  • Bloomberg

EU Urges Wine, Spirits Tariff Cut as 15% US Duty Irks Industry

By and Max Ramsay Save European officials said they'll keep pressing for lower tariffs on wine and spirits, after a trade agreement with the US prompted an outcry from the industry by leaving exports to America subject to 15% levies. At issue is the treatment of Champagne, liquor and other alcohol products shipped to the US, a top market for the bloc's wine and spirits. For weeks, European leaders have unsuccessfully lobbied US officials to exempt the products from President Donald Trump's so-called reciprocal tariffs.

As The TikTok Ban Looms, White House Launches A New Account On The App
As The TikTok Ban Looms, White House Launches A New Account On The App

Forbes

time14 minutes ago

  • Forbes

As The TikTok Ban Looms, White House Launches A New Account On The App

You would think the drama over a TikTok ban would have been resolved by now. Instead, in a move that can only be meant to change the optics related to TikTok's future, the White House launched a new account on the platform, which is used by about 170 million Americans. The first clip on @whitehouse features President Trump in a promo saying 'I am your voice' with a caption about America being back. The account already has a handful of videos available, but most of them are about President Trump. History of the TikTok ban It's another twist in a story that is hard to pin down. I've been writing about the TikTok ban from the beginning, covering all of the twists and turns. Here's a highly condensed recap. First, U.S. officials started recognizing that the Chinese-owned app could be used as a surveillance tool. Former President Joe Biden signed a law making the app illegal to distribute on app stores last spring, but President Trump has delayed enforcing the ban multiple times since then. We're now approaching the next deadline for an extension on September 17. Meanwhile, the timing of the new White House account seems odd considering the ban is supposed to go into effect again in a few weeks. Still, it's hard to take these expiration dates and possible extensions seriously because President Trump is an advocate for keeping the social media app around. Now that he is using a new account, it seems even more likely that he will extend the ban again. Why a TikTok ban seems more likely The issue here is one of legality, not preference. President Trump is going a bit rogue because lawmakers never intended the ban to be extended this many times. Trump has found a workaround by issuing executive orders to delay the ban, which he has the right to do, but the original ruling was meant to address a foreign threat and had timelines for enforcement built-in. We're now facing an uncertain future, especially if you are a TikTok creator or rely on the app to help you find places to eat or discover new music, like me. One recent report notes that Commerce Secretary Howard Lutnick thinks TikTok won't survive much longer. 'It's got to come out of Chinese control,' said Lutnick on CNBC. 'We've made the decision. You can't have Chinese control and have something on a hundred million American phones. That's just not OK.' Another report claimed ByteDance, the company that owns TikTok, is working on a new app that will be released on September 5. Users will be forced to switch to the new version, which hints at the possibility the current version won't be around that much longer. What the TikTok ban really means The basic summary here is that no one really knows what will happen. For fans of the app, content creators, and even those who are pushing for freedom of speech and have a hard time accepting that the federal government has any role to play on social media platforms, it feels like this time there may be an actual change. A new app? An actual ban? Life as usual? Come September, we'll know a lot more about whether a TikTok ban could actually happen.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store